-
1
-
2
-
3
-
4
-
5
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis
Veröffentlicht 2023kostenfrei
kostenfrei
Elektronisch E-Book -
6
-
7